K. Kaminsky‐Russ

Endogenous benzodiazepine activity in the peripheral and portal blood of dogs with congenital portosystemic shunts.

C. Gregory, K. Mullen, L. Aronson, 1997, Veterinary surgery : VS.

"Endogenous" benzodiazepine activity in body fluids of patients with hepatic encephalopathy

K. Szauter, K. Mullen, K. Kaminsky‐Russ, 1990, The Lancet.

Alteration in body composition in the portacaval anastamosis rat is mediated by increased expression of myostatin.

A. McCullough, K. Mullen, S. Dasarathy, 2011, American journal of physiology. Gastrointestinal and liver physiology.

Preservation of Portal Pressure Improves Growth and Metabolic Profile in the Male Portacaval-Shunted Rat

H. Conjeevaram, A. McCullough, K. Mullen, 2002, Digestive Diseases and Sciences.

Reversal of behavioral changes in rats subjected to portacaval shunt with oral neomycin therapy

H. Conjeevaram, A. McCullough, K. Mullen, 1994, Hepatology.

Pathogenesis of hepatic encephalopathy: potential future approaches.

K. Mullen, K. Kaminsky‐Russ, 1996, Digestive diseases.

Evidence for the presence of a benzodiazepine receptor binding substance in cerebrospinal fluid of a rabbit model of hepatic encephalopathy

W. Mendelson, E. Jones, J. V. Martin, 1989, Metabolic Brain Disease.

Detection of benzodiazepine‐like activity in hepatic encephalopathy requires an initial lipophilic extraction procedure!

A. Zimmermann, K. Mullen, H. Fisch, 1994, Hepatology.

Reversal of behavioral changes in rats subjected to portacaval shunt with oral neomycin therapy

H. Conjeevaram, A. McCullough, K. Mullen, 1994, Hepatology.